Legend Biotech (LEGN) Revenue Growth (1y) (2020 - 2025)
Legend Biotech (LEGN) Revenue Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 64.30% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | 64.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 64.24% |
| Sep 30, 2025 | 69.99% |
| Jun 30, 2025 | 36.74% |
| Mar 31, 2025 | 107.52% |
| Dec 31, 2024 | -99.77% |
| Sep 30, 2024 | 66.86% |
| Jun 30, 2024 | 154.36% |
| Mar 31, 2024 | 158.67% |
| Dec 31, 2023 | 287,469.21% |
| Sep 30, 2023 | 250.91% |
| Jun 30, 2023 | 512.56% |
| Mar 31, 2023 | -27.39% |
| Dec 31, 2022 | -29.14% |
| Sep 30, 2022 | 62.07% |
| Jun 30, 2022 | -40.83% |
| Mar 31, 2022 | 265.74% |
| Dec 31, 2021 | -4.38% |
| Sep 30, 2021 | 43.71% |
| Jun 30, 2021 | 74.42% |
| Mar 31, 2021 | 18.50% |